• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by Nano Dimension Ltd.

    10/11/24 4:47:45 PM ET
    $NNDM
    Electrical Products
    Technology
    Get the next $NNDM alert in real time by email
    SC 13D/A 1 sc13da1313459002_10112024.htm AMENDMENT NO. 13 TO THE SCHEDULE 13D

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13D

    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

    (Amendment No. 13)1

    Nano Dimension Ltd.

    (Name of Issuer)

    Ordinary Shares par value NIS 5.00 per share

    (Title of Class of Securities)

    63008G203

    (CUSIP Number)

    MURCHINSON LTD.

    145 Adelaide Street West, Fourth Floor

    Toronto, Ontario Canada A6 M5H 4E5

    (416) 845-0666

     

    ANDREW FREEDMAN, ESQ.

    MEAGAN REDA, ESQ.

    OLSHAN FROME WOLOSKY LLP

    1325 Avenue of the Americas

    New York, New York 10019

    (212) 451-2300

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    October 9, 2024

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

    Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 63008G203

      1   NAME OF REPORTING PERSON  
             
            Murchinson Ltd.  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Canada  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         7,775,000*  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         7,775,000*#  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              7,775,000*  
        10   SHARED DISPOSITIVE POWER  
               
              7,775,000*#  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            15,550,000*#  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            7.1%  
      14   TYPE OF REPORTING PERSON  
             
            CO  

      

    * Represents American Depositary Shares (“ADSs”) (each ADS represents one Ordinary Share). See Item 4 for additional detail regarding the ADS Conversion (as defined therein) that is currently taking place.

    # Includes 3,000,000 Ordinary Shares.

    2

    CUSIP No. 63008G203

      1   NAME OF REPORTING PERSON  
             
            Nomis Bay Ltd  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Bermuda  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         4,665,000*#  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              4,665,000*#  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            4,665,000*#  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            2.1%  
      14   TYPE OF REPORTING PERSON  
             
            CO  

      

    * Represents American Depositary Shares (“ADSs”) (each ADS represents one Ordinary Share). See Item 4 for additional detail regarding the ADS Conversion (as defined therein) that is currently taking place.

    # Includes 3,000,000 Ordinary Shares.

    3

    CUSIP No. 63008G203

     

      1   NAME OF REPORTING PERSON  
             
            BPY Limited  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Bermuda  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         3,110,000*  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              3,110,000*  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            3,110,000*  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            1.4%  
      14   TYPE OF REPORTING PERSON  
             
            CO  

      

    * Represents American Depositary Shares (“ADSs”) (each ADS represents one Ordinary Share). See Item 4 for additional detail regarding the ADS Conversion (as defined therein) that is currently taking place.

    4

    CUSIP No. 63008G203

     

      1   NAME OF REPORTING PERSON  
             
            EOM Management Ltd.  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Bermuda  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         7,775,000*#  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              7,775,000*#  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            7,775,000*#  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            3.5%  
      14   TYPE OF REPORTING PERSON  
             
            CO  

      

    * Represents American Depositary Shares (“ADSs”) (each ADS represents one Ordinary Share). See Item 4 for additional detail regarding the ADS Conversion (as defined therein) that is currently taking place.

    # Includes 3,000,000 Ordinary Shares.

    5

    CUSIP No. 63008G203

     

      1   NAME OF REPORTING PERSON  
             
            James Keyes  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            United Kingdom  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         7,775,000*#  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              7,775,000*#  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            7,775,000*#  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            3.5%  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    * Represents American Depositary Shares (“ADSs”) (each ADS represents one Ordinary Share). See Item 4 for additional detail regarding the ADS Conversion (as defined therein) that is currently taking place.

    # Includes 3,000,000 Ordinary Shares.

    6

    CUSIP No. 63008G203

     

      1   NAME OF REPORTING PERSON  
             
            Jason Jagessar  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Republic of Trinidad and Tobago  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         7,775,000*#  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              7,775,000*#  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            7,775,000*#  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            3.5%  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    * Represents American Depositary Shares (“ADSs”) (each ADS represents one Ordinary Share). See Item 4 for additional detail regarding the ADS Conversion (as defined therein) that is currently taking place.

    # Includes 3,000,000 Ordinary Shares.

    7

    CUSIP No. 63008G203

     

      1   NAME OF REPORTING PERSON  
             
            Chaja Carlebach  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Switzerland  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         7,775,000*#  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              7,775,000*#  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            7,775,000*#  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            3.5%  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    * Represents American Depositary Shares (“ADSs”) (each ADS represents one Ordinary Share). See Item 4 for additional detail regarding the ADS Conversion (as defined therein) that is currently taking place.

    # Includes 3,000,000 Ordinary Shares.

    8

    CUSIP No. 63008G203

     

      1   NAME OF REPORTING PERSON  
             
            Marc J. Bistricer  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Canada  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         7,775,000*  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         7,775,000*#  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              7,775,000*  
        10   SHARED DISPOSITIVE POWER  
               
              7,775,000*#  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            15,550,000*#  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            7.1%  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    * Represents American Depositary Shares (“ADSs”) (each ADS represents one Ordinary Share). See Item 4 for additional detail regarding the ADS Conversion (as defined therein) that is currently taking place.

    # Includes 3,000,000 Ordinary Shares.

    9

    CUSIP No. 63008G203

     

    The following constitutes Amendment No. 13 to the Schedule 13D filed by the undersigned (the “Amendment No. 13”). This Amendment No. 13 amends the Schedule 13D as specifically set forth herein.

    Item 4.Purpose of Transaction.

    Item 4 is hereby amended to add the following:

    On October 9, 2024, Murchinson delivered a letter (the “Letter”) to the Issuer’s Board of Directors (the “Board”), in which, among other things, Murchinson (i) reminded the Issuer of its continued delay in holding this year’s Annual General Meeting of Shareholders (the “AGM”), (ii) expressed its concerns that, as part of the Board’s continued efforts to disenfranchise shareholders, it appears that the Board plans to hold the AGM at the latest day possible under Israeli law, and (iii) informed the Board that given the upcoming AGM and the Board’s history of concerning actions and apparent attempts to disenfranchise shareholders, Murchinson has requested to convert a portion of the ADSs held by Nomis Bay, BPY and the Managed Positions into Ordinary Shares (the “ADS Conversion”).

    In the Letter, Murchinson also notified the Board that it intends to submit certain proposals for inclusion on the agenda at the AGM, including (i) the nomination of two to three director candidates, (ii) the removal of one or more incumbent directors, and (iii) certain amendments to the Issuer’s Articles of Association, including an amendment regarding the need to obtain shareholder approvals for major transactions. To that end, Murchinson invited the Board to engage with Murchinson in good faith to ensure that the Issuer’s proxy materials for the AGM include the proposals Murchinson intends to submit in a manner that will ensure shareholders are presented with a clear agenda for the AGM. The foregoing description of the Letter does not purport to be complete and is qualified in its entirety by reference to the Letter, which is incorporated herein by reference as Exhibit 99.1 hereto.

    The ADS Conversion is currently taking place; however, completion of such conversion is outside of the control of the Reporting Persons. As part of the ADS Conversion, Nomis Bay, BPY and Murchinson, on behalf of the Managed Positions, surrendered and withdrew certain of their respective ADSs to BNYM, the depositary (“BNYM”) and requested delivery of the underlying Ordinary Shares.

    Item 5.Interest in the Securities of the Issuer.

    Item 5(c) is hereby amended to add the following:

    Other than the ADS Conversion defined and described in Item 4 above, which is currently taking place, there have been no transactions in the Shares by the Reporting Persons during the past sixty days.

    Item 7.Material to be Filed as Exhibits.

    Item 7 is hereby amended to add the following exhibit:

    99.1Letter to the Board of Directors of the Issuer, dated October 9, 2024.

    10

    CUSIP No. 63008G203

    SIGNATURES

     

    After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: October 11, 2024

      Nomis Bay Ltd
       
      By:

    /s/ James Keyes

        Name: James Keyes
        Title: Director

     

     

      BPY Limited
       
      By:

    /s/ James Keyes

        Name: James Keyes
        Title: Director

     

     

      EOM Management Ltd.
       
      By:

    /s/ Chaja Carlebach

        Name: Chaja Carlebach
        Title: Director

     

     

      Murchinson Ltd.
       
      By:

    /s/ Marc J. Bistricer

        Name: Marc J. Bistricer
        Title: Chief Executive Officer

     

     

     

    /s/ James Keyes

      James Keyes

     

     

     

    /s/ Jason Jagessar

      Jason Jagessar

     

     

     

    /s/ Chaja Carlebach

      Chaja Carlebach

     

     

     

    /s/ Marc J. Bistricer

      Marc J. Bistricer

     

     

    11

    Get the next $NNDM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NNDM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NNDM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

    WALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") today announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer ("CEO"), effective immediately. The Company’s Board of Directors (the "Board") has also appointed Phillip Borenstein as Chairman of the Board. Mr. Rozenbaum will work closely with the Board and the Company’s leadership to support business continuity while the Board evaluates the Company’s strategic priorities and opportunities moving forward. Phillip Borenstein, Chairman of the Board, commented, "On behalf of myself and the entire Board of Directors, we are pleased to appoint

    7/21/26 4:05:00 PM ET
    $NNDM
    $LFWD
    Electrical Products
    Technology
    Industrial Specialties
    Health Care

    Nano Dimension and Murchinson Announce Agreement to Reconstitute the Company’s Board of Directors

    WALTHAM, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- In connection with the upcoming July 31, 2026, Extraordinary General Meeting of Shareholders (the "July EGM"), Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano," or the "Company") and Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson") today jointly announced a settlement agreement. Under the terms of the agreement executed on July 17, the July EGM will be cancelled. Messrs. Pons, Rosensweig, Sriubas and Stehlin (collectively, the "Departing Directors") resigned from the Board and all their positions at Nano. The directors nominated by Murchinson for the July EGM — Messrs. Fruc

    7/20/26 8:30:00 AM ET
    $NNDM
    Electrical Products
    Technology

    QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

    Ness Ziona, Israel, July 17, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, today announced that on July 14, 2026, its Board of Directors (the "Board") appointed Dr. Shlomit Chappel-Ram as an independent director, effective immediately. Dr. Chappel-Ram previously served as Vice President of R&D at Nano Dimension Ltd. (NASDAQ:NNDM), where she led multidisciplinary teams spanning materials, formulations, chemistry, physics, process engineering, mechanics, software, hardware, and electronics. She also co-authored peer-reviewed IEEE research o

    7/17/26 8:30:00 AM ET
    $IINN
    $NNDM
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology

    $NNDM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Stehlin David covered exercise/tax liability with 24,971 units of Ordinary Shares, decreasing direct ownership by 3% to 737,032 units (SEC Form 4) to satisfy withholding obligation

    4 - Nano Dimension Ltd. (0001643303) (Issuer)

    7/14/26 4:15:13 PM ET
    $NNDM
    Electrical Products
    Technology

    Chief Executive Officer Stehlin David covered exercise/tax liability with 19,841 units of Ordinary Shares, decreasing direct ownership by 3% to 762,003 units (SEC Form 4) to satisfy tax liability

    4 - Nano Dimension Ltd. (0001643303) (Issuer)

    6/10/26 4:15:18 PM ET
    $NNDM
    Electrical Products
    Technology

    Director Sriubas Andrew was granted 160,000 units of Ordinary Shares, increasing direct ownership by 400% to 200,015 units (SEC Form 4)

    4 - Nano Dimension Ltd. (0001643303) (Issuer)

    6/4/26 4:01:49 PM ET
    $NNDM
    Electrical Products
    Technology

    $NNDM
    SEC Filings

    View All

    SEC Form 8-K filed by Nano Dimension Ltd.

    8-K - Nano Dimension Ltd. (0001643303) (Filer)

    7/21/26 4:05:15 PM ET
    $NNDM
    Electrical Products
    Technology

    SEC Form 144 filed by Nano Dimension Ltd.

    144 - Nano Dimension Ltd. (0001643303) (Subject)

    7/14/26 7:54:34 AM ET
    $NNDM
    Electrical Products
    Technology

    SEC Form DEFA14A filed by Nano Dimension Ltd.

    DEFA14A - Nano Dimension Ltd. (0001643303) (Filer)

    7/10/26 9:15:18 AM ET
    $NNDM
    Electrical Products
    Technology

    $NNDM
    Leadership Updates

    Live Leadership Updates

    View All

    Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

    WALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") today announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer ("CEO"), effective immediately. The Company’s Board of Directors (the "Board") has also appointed Phillip Borenstein as Chairman of the Board. Mr. Rozenbaum will work closely with the Board and the Company’s leadership to support business continuity while the Board evaluates the Company’s strategic priorities and opportunities moving forward. Phillip Borenstein, Chairman of the Board, commented, "On behalf of myself and the entire Board of Directors, we are pleased to appoint

    7/21/26 4:05:00 PM ET
    $NNDM
    $LFWD
    Electrical Products
    Technology
    Industrial Specialties
    Health Care

    QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

    Ness Ziona, Israel, July 17, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, today announced that on July 14, 2026, its Board of Directors (the "Board") appointed Dr. Shlomit Chappel-Ram as an independent director, effective immediately. Dr. Chappel-Ram previously served as Vice President of R&D at Nano Dimension Ltd. (NASDAQ:NNDM), where she led multidisciplinary teams spanning materials, formulations, chemistry, physics, process engineering, mechanics, software, hardware, and electronics. She also co-authored peer-reviewed IEEE research o

    7/17/26 8:30:00 AM ET
    $IINN
    $NNDM
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology

    Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

    WALTHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") and Infinite Epigenetics™ ("Infinite Epigenetics," "Infinite") today issued the following shareholder update to provide additional detail on the proposed business combination announced on June 15, 2026. The Company has carefully reviewed Murchinson's recent letter regarding the proposed transaction with Infinite. While we welcome shareholder engagement and are committed to transparency, the final details of the transaction are still being negotiated. However, we would like to address specific questions posed by Murchinson, contextualize the Infinite story and com

    6/16/26 7:43:26 PM ET
    $NNDM
    Electrical Products
    Technology

    $NNDM
    Financials

    Live finance-specific insights

    View All

    Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

    Believes the Proposed Transaction Represents a Misallocation of Corporate Resources That Would Significantly Dilute Existing Shareholders Finds It Deeply Concerning That This Morning's Conference Call Offered Shareholders Little Beyond Buzzwords and Provided No Opportunity to Ask Questions Regarding a Transaction That Materially Impacts the Future of the Company Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today commented on Nano's announcement that it has signed a non-binding term

    6/15/26 5:55:00 PM ET
    $NNDM
    Electrical Products
    Technology

    Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

    Nano Dimension Conducted a Rigorous Multi-Month Strategic Review, Assessing Approximately 20 Companies Before Selecting Infinite Epigenetics as the Most Compelling Path to Long-Term Value CreationProposed Combination Would Deploy Nano Dimension's Capital Base and Nasdaq listing into a High-Growth Healthcare AI OpportunityExisting Nano Shareholders Expected to Retain Meaningful Minority Ownership in Combined Company on a Stated Value for Nano Dimension's Shares that Reflects a 20% Premium to Nano Dimension's Estimated Net Cash at ClosingInfinite Epigenetics Transaction Value of $890 million Infinite Epigenetics Targets a $90B+ U.S. Clinical Diagnostics Market Opportunity Across its Core Disea

    6/15/26 7:27:56 AM ET
    $NNDM
    Electrical Products
    Technology

    Murchinson Invites Fellow Nano Dimension Shareholders to an Investor Call to Discuss the Current State of the Company

    It Is Time to Talk About Nano Dimension Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today announced it will host an investor conference call to discuss the Company's so-called strategic review, Chairman Bob Pons' role in the "review process," and other concerns related to the Company's business and corporate governance. After eight months of limited progress and minimal communication from Nano regarding its strategic review, Murchinson believes shareholders deserve a constructive

    5/26/26 5:00:00 PM ET
    $NNDM
    Electrical Products
    Technology

    $NNDM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Nano Dimension Ltd.

    SC 13D/A - Nano Dimension Ltd. (0001643303) (Subject)

    11/13/24 11:31:24 AM ET
    $NNDM
    Electrical Products
    Technology

    Amendment: SEC Form SC 13D/A filed by Nano Dimension Ltd.

    SC 13D/A - Nano Dimension Ltd. (0001643303) (Subject)

    10/23/24 8:21:43 PM ET
    $NNDM
    Electrical Products
    Technology

    Amendment: SEC Form SC 13D/A filed by Nano Dimension Ltd.

    SC 13D/A - Nano Dimension Ltd. (0001643303) (Subject)

    10/11/24 4:47:45 PM ET
    $NNDM
    Electrical Products
    Technology